Correlation Between Coya Therapeutics, and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and INmune Bio, you can compare the effects of market volatilities on Coya Therapeutics, and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and INmune Bio.
Diversification Opportunities for Coya Therapeutics, and INmune Bio
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Coya and INmune is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and INmune Bio go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and INmune Bio
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the INmune Bio. In addition to that, Coya Therapeutics, is 1.97 times more volatile than INmune Bio. It trades about -0.25 of its total potential returns per unit of risk. INmune Bio is currently generating about -0.27 per unit of volatility. If you would invest 617.00 in INmune Bio on August 29, 2024 and sell it today you would lose (129.00) from holding INmune Bio or give up 20.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. INmune Bio
Performance |
| Timeline |
| Coya Therapeutics, Common |
| INmune Bio |
Coya Therapeutics, and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and INmune Bio
The main advantage of trading using opposite Coya Therapeutics, and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |